FDA Warns P&G Over Contamination Risk At Plant
In a letter dated April 24 and posted on the FDA's Web site Tuesday, the agency told the company that inspections of the facility in Cayey, Puerto Rico, revealed deviations from the Current Good Manufacturing Practice Regulations in the Federal Food, Drug and Cosmetic Act.
The letter, sent in response to inspections between Aug. 25 and Oct. 1,...
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login